A potential biomarker for anti-PD-1 immunotherapy

Nat Med. 2018 Feb 7;24(2):123-124. doi: 10.1038/nm.4489.

Authors

Sangeeta Goswami¹, Sreyashi Basu², Padmanee Sharma²

Affiliations

¹ Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 29414936
DOI: 10.1038/nm.4489

No abstract available

Publication types

Comment

MeSH terms

B7-H1 Antigen / analysis
Biomarkers
Immunotherapy
Programmed Cell Death 1 Receptor*
Single-Cell Analysis*

Substances

B7-H1 Antigen
Biomarkers
Programmed Cell Death 1 Receptor